<DOC>
	<DOCNO>NCT01435382</DOCNO>
	<brief_summary>This Phase 1 study design evaluate absolute bioavailability PF-04950615 subject hypercholesterolemia currently lipid-lowering therapy .</brief_summary>
	<brief_title>A Pharmacokinetic Pharmacodynamic Study PF-04950615 Subjects With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Fasting LDLC great equal 130 mg/dL two qualify screen visit . Total body weight great equal 50 kg ( 110 lb ) less equal 150 kg ( 330 lb ) Lipidlowering prescription medication , homeopath , herbal medicine , nutritional supplement . Poorly control type 1 type 2 diabetes . History cardiovascular cerebrovascular event related procedure past year . Poorly control hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>